170 related articles for article (PubMed ID: 23573363)
1. Genetically reprogrammed, liver-derived insulin-producing cells are glucose-responsive, but susceptible to autoimmune destruction in settings of murine model of type 1 diabetes.
Tang DQ; Shun L; Koya V; Sun Y; Wang Q; Wang H; Li SW; Sun Y; Purich DL; Zhang C; Hansen B; Qian K; Atkinson M; Phillips MI; Yang LJ
Am J Transl Res; 2013; 5(2):184-99. PubMed ID: 23573363
[TBL] [Abstract][Full Text] [Related]
2. PDX1-engineered embryonic stem cell-derived insulin producing cells regulate hyperglycemia in diabetic mice.
Raikwar SP; Zavazava N
Transplant Res; 2012 Oct; 1(1):19. PubMed ID: 23369186
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic insulin-producing cells differentiated from human embryonic stem cells correct hyperglycemia in SCID/NOD mice, an animal model of diabetes.
Hua XF; Wang YW; Tang YX; Yu SQ; Jin SH; Meng XM; Li HF; Liu FJ; Sun Q; Wang HY; Li JY
PLoS One; 2014; 9(7):e102198. PubMed ID: 25009980
[TBL] [Abstract][Full Text] [Related]
4. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
Sharma A; Rani R
Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
[TBL] [Abstract][Full Text] [Related]
5. High glucose is necessary for complete maturation of Pdx1-VP16-expressing hepatic cells into functional insulin-producing cells.
Cao LZ; Tang DQ; Horb ME; Li SW; Yang LJ
Diabetes; 2004 Dec; 53(12):3168-78. PubMed ID: 15561947
[TBL] [Abstract][Full Text] [Related]
6. Improvement of the therapeutic capacity of insulin-producing cells trans-differentiated from human liver cells using engineered cell sheet.
Lee YN; Yi HJ; Seo EH; Oh J; Lee S; Ferber S; Okano T; Shim IK; Kim SC
Stem Cell Res Ther; 2021 Jan; 12(1):3. PubMed ID: 33407888
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice.
Dao LT; Park EY; Lim SM; Choi YS; Jung HS; Jun HS
Transplantation; 2014 Nov; 98(10):1040-7. PubMed ID: 25208321
[TBL] [Abstract][Full Text] [Related]
8. Role of Pax4 in Pdx1-VP16-mediated liver-to-endocrine pancreas transdifferentiation.
Tang DQ; Cao LZ; Chou W; Shun L; Farag C; Atkinson MA; Li SW; Chang LJ; Yang LJ
Lab Invest; 2006 Aug; 86(8):829-41. PubMed ID: 16732298
[TBL] [Abstract][Full Text] [Related]
9. Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus.
Amer MG; Embaby AS; Karam RA; Amer MG
Gene; 2018 May; 654():87-94. PubMed ID: 29452233
[TBL] [Abstract][Full Text] [Related]
10. Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.
Xin Y; Jiang X; Wang Y; Su X; Sun M; Zhang L; Tan Y; Wintergerst KA; Li Y; Li Y
PLoS One; 2016; 11(1):e0145838. PubMed ID: 26756576
[TBL] [Abstract][Full Text] [Related]
11. The combined effect of
Hashemi Tabar M; Tabandeh MR; Moghimipour E; Dayer D; Ghadiri AA; Allah Bakhshi E; Orazizadeh M; Ghafari MA
FEBS Open Bio; 2018 Mar; 8(3):372-382. PubMed ID: 29511614
[TBL] [Abstract][Full Text] [Related]
12. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
[TBL] [Abstract][Full Text] [Related]
13. Insulin-producing cells derived from rat bone marrow and their autologous transplantation in the duodenal wall for treating diabetes.
Zhang YH; Wang HF; Liu W; Wei B; Bing LJ; Gao YM
Anat Rec (Hoboken); 2009 May; 292(5):728-35. PubMed ID: 19382247
[TBL] [Abstract][Full Text] [Related]
14. Glucosamine potentiates the differentiation of adipose-derived stem cells into glucose-responsive insulin-producing cells.
Hong Y; Park EY; Kim D; Lee H; Jung HS; Jun HS
Ann Transl Med; 2020 Apr; 8(8):561. PubMed ID: 32775362
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of insulin-producing cells derived from human MSCs to treat diabetes in a non-human primate model.
Zhoujun Z; Bingzheng F; Yuwei Y; Yingying Z; Zhiran X; Chunhua H; Jing L; Haibo T; Wanli L; Ting Z; Fujun L; Jibing C; Hongjun G
Artif Organs; 2023 Aug; 47(8):1298-1308. PubMed ID: 37032529
[TBL] [Abstract][Full Text] [Related]
16. Reversal of streptozotocin-induced diabetes in mice by cellular transduction with recombinant pancreatic transcription factor pancreatic duodenal homeobox-1: a novel protein transduction domain-based therapy.
Koya V; Lu S; Sun YP; Purich DL; Atkinson MA; Li SW; Yang LJ
Diabetes; 2008 Mar; 57(3):757-69. PubMed ID: 18086901
[TBL] [Abstract][Full Text] [Related]
17. An Efficient and Footprint-Free Protocol for the Transdifferentiation of Hepatocytes Into Insulin-Producing Cells With IVT mRNAs.
Ma S; Yang M; Zhou W; Dai L; Ding Y; Guo X; Yuan Y; Tang J; Li D; Wang X
Front Genet; 2020; 11():575. PubMed ID: 32655618
[TBL] [Abstract][Full Text] [Related]
18. Endogenous Reprogramming of Alpha Cells into Beta Cells, Induced by Viral Gene Therapy, Reverses Autoimmune Diabetes.
Xiao X; Guo P; Shiota C; Zhang T; Coudriet GM; Fischbach S; Prasadan K; Fusco J; Ramachandran S; Witkowski P; Piganelli JD; Gittes GK
Cell Stem Cell; 2018 Jan; 22(1):78-90.e4. PubMed ID: 29304344
[TBL] [Abstract][Full Text] [Related]
19. Syngeneically transplanted insulin producing cells differentiated from adipose derived stem cells undergo delayed damage by autoimmune responses in NOD mice.
Tokuda K; Ikemoto T; Yamashita S; Miyazaki K; Okikawa S; Yamada S; Saito Y; Morine Y; Shimada M
Sci Rep; 2022 Apr; 12(1):5852. PubMed ID: 35393479
[TBL] [Abstract][Full Text] [Related]
20. Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes.
Gerling IC; Friedman H; Greiner DL; Shultz LD; Leiter EH
Diabetes; 1994 Mar; 43(3):433-40. PubMed ID: 8314017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
